Document is current
Any future updates will be listed below
-
Authors
Suzuki, Keisuke
Suzuki, Shiho
Haruyama, Yasuo
Shioda, Mukuto
Kobayashi, Saro
Hida, Ryotaro
Hirata, Koichi
-
Funding
Funding for this research was provided by:
Eli Lilly Japan
- License Information
-
More Information
Article History
Received: 17 January 2026
Accepted: 16 March 2026
First Online: 20 March 2026
Declarations
:
: The study was conducted in compliance with the principles of the Declaration of Helsinki and was approved by the Institutional Review Board of Dokkyo Medical University Hospital (approval number: R-72–5 J).
: Not applicable.
: The authors declare the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article. K Suzuki received lecture fees from Eli Lilly Japan, Daiichi Sankyo and Otsuka Pharmaceutical Co., Ltd., during this study. S Suzuki received lecture fees from Eli Lilly Japan, Daiichi Sankyo, Amgen and Otsuka Pharmaceutical Co., Ltd., during this study. Y Haruyama, M Shioda, S Kobayashi and R Hida have nothing to disclose. K Hirata received lecture fees from Eli Lilly Japan, Daiichi Sankyo, Amgen and Otsuka Pharmaceutical Co., Ltd., during this study.
